These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 17474330

  • 1. The case for a value-based formulary: striving for total lowest net cost.
    Weart W, Bauman GR.
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC, Martin RE.
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [Abstract] [Full Text] [Related]

  • 5. The drug formulary decision-making process.
    Brehany J, Cohen P, Sax MJ.
    Healthplan; 1999 Jul; 40(3):85-92. PubMed ID: 10538088
    [No Abstract] [Full Text] [Related]

  • 6. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
    Bukstein DA.
    Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
    [Abstract] [Full Text] [Related]

  • 7. Evidence-based decision making in managed care pharmacy.
    Penna P.
    Manag Care Interface; 2002 May; 15(5):43-4. PubMed ID: 12024870
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G.
    J Clin Psychiatry; 2003 May; 64 Suppl 17():29-32. PubMed ID: 14680425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increasing stakes and complex dynamics in the formulary process.
    Tadlock C.
    Manag Care Interface; 2007 Mar; 20(3):12, 14. PubMed ID: 17458473
    [No Abstract] [Full Text] [Related]

  • 12. Showing outcomes and proving value brings success.
    Fullerton DS, Atherly D, Sullivan SD.
    Manag Care Interface; 2001 Jun; 14(6):63-5, 71. PubMed ID: 11432153
    [Abstract] [Full Text] [Related]

  • 13. Formulary decision-making considerations: COX-2 inhibitors.
    Shaya FT, Wong W, Shin JY, Martin L, Samant N.
    Manag Care Interface; 2004 Nov; 17(11):29-36, 41. PubMed ID: 15573802
    [Abstract] [Full Text] [Related]

  • 14. Controlling the cost of branded drugs.
    Mandelker J.
    Bus Health; 1993 Nov; 11(13):44-6, 48. PubMed ID: 10130506
    [Abstract] [Full Text] [Related]

  • 15. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
    Fry RN, Avey SG, Sullivan SD.
    Value Health; 2003 Nov; 6(5):505-21. PubMed ID: 14627057
    [Abstract] [Full Text] [Related]

  • 16. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
    Skaer TL.
    Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Formulary submission process catches on ... slowly.
    Cross M.
    Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856
    [No Abstract] [Full Text] [Related]

  • 20. Managing prescription drug costs.
    Sica JM.
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.